![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | RGD:1561190 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NR2C2AP mRNA] | CTD | PMID:31150632 | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1606467 | 6480464 | [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of NR2C2AP mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of NR2C2AP mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NR2C2AP mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of NR2C2AP mRNA | CTD | PMID:21570461 | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | ISO | RGD:1561190 | 6480464 | 2 more ... | CTD | PMID:32109520 | 4-hydroxyphenyl retinamide | decreases expression | EXP | | 6480464 | Fenretinide results in decreased expression of NR2C2AP mRNA | CTD | PMID:28973697 | aflatoxin B1 | increases expression | ISO | RGD:1606467 | 6480464 | Aflatoxin B1 results in increased expression of NR2C2AP mRNA | CTD | PMID:22100608 | all-trans-retinoic acid | decreases expression | ISO | RGD:1606467 | 6480464 | Tretinoin results in decreased expression of NR2C2AP mRNA | CTD | PMID:23724009 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzoapyrene results in decreased expression of NR2C2AP mRNA | CTD | PMID:19770486 | benzo[a]pyrene | increases expression | ISO | RGD:1606467 | 6480464 | Benzoapyrene results in increased expression of NR2C2AP mRNA | CTD | PMID:32234424 | benzo[a]pyrene | decreases methylation | ISO | RGD:1606467 | 6480464 | Benzoapyrene results in decreased methylation of NR2C2AP 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | RGD:1606467 | 6480464 | Benzoapyrene results in increased methylation of NR2C2AP promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzoapyrene results in increased expression of NR2C2AP mRNA | CTD | PMID:22228805 | bisphenol A | increases expression | ISO | RGD:1561190 | 6480464 | bisphenol A results in increased expression of NR2C2AP mRNA | CTD | PMID:25181051 | calcitriol | decreases expression | ISO | RGD:1606467 | 6480464 | Calcitriol results in decreased expression of NR2C2AP mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | ISO | RGD:1606467 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of NR2C2AP mRNA | CTD | PMID:21592394 | chromium(6+) | decreases expression | ISO | RGD:1606467 | 6480464 | chromium hexavalent ion results in decreased expression of NR2C2AP mRNA | CTD | PMID:30690063 | cisplatin | increases expression | ISO | RGD:1606467 | 6480464 | Cisplatin results in increased expression of NR2C2AP mRNA | CTD | PMID:27392435 | coumestrol | increases expression | ISO | RGD:1606467 | 6480464 | Coumestrol results in increased expression of NR2C2AP mRNA | CTD | PMID:19167446 | cyclosporin A | increases expression | ISO | RGD:1606467 | 6480464 | Cyclosporine results in increased expression of NR2C2AP mRNA | CTD | PMID:25562108 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of NR2C2AP mRNA | CTD | PMID:21266533 | endosulfan | increases expression | ISO | RGD:1561190 | 6480464 | Endosulfan results in increased expression of NR2C2AP mRNA | CTD | PMID:29391264 | flutamide | increases expression | ISO | RGD:1561190 | 6480464 | Flutamide results in increased expression of NR2C2AP mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | EXP | | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NR2C2AP mRNA | CTD | PMID:22206623 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of NR2C2AP mRNA | CTD | PMID:25629700 | methyl methanesulfonate | increases expression | ISO | RGD:1606467 | 6480464 | Methyl Methanesulfonate results in increased expression of NR2C2AP mRNA | CTD | PMID:23649840 | nefazodone | increases expression | ISO | RGD:1561190 | 6480464 | nefazodone results in increased expression of NR2C2AP mRNA | CTD | PMID:24136188 | perfluorononanoic acid | increases expression | ISO | RGD:1606467 | 6480464 | perfluorononanoic acid results in increased expression of NR2C2AP mRNA | CTD | PMID:32588087 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NR2C2AP mRNA | CTD | PMID:19710929 | potassium chromate | multiple interactions | ISO | RGD:1606467 | 6480464 | [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of NR2C2AP mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | RGD:1606467 | 6480464 | potassium chromateVI results in decreased expression of NR2C2AP mRNA | CTD | PMID:22079256, PMID:22714537 | rotenone | increases expression | ISO | RGD:1561190 | 6480464 | Rotenone results in increased expression of NR2C2AP mRNA | CTD | PMID:28374803 | sunitinib | increases expression | ISO | RGD:1606467 | 6480464 | Sunitinib results in increased expression of NR2C2AP mRNA | CTD | PMID:31533062 | testosterone | decreases expression | ISO | RGD:1606467 | 6480464 | Testosterone results in decreased expression of NR2C2AP mRNA | CTD | PMID:21592394 | testosterone | multiple interactions | ISO | RGD:1606467 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of NR2C2AP mRNA | CTD | PMID:21592394 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of NR2C2AP mRNA | CTD | PMID:27339419, PMID:31919559 | tetrachloromethane | multiple interactions | ISO | RGD:1561190 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NR2C2AP mRNA] | CTD | PMID:31150632 | tetrachloromethane | increases expression | ISO | RGD:1561190 | 6480464 | Carbon Tetrachloride results in increased expression of NR2C2AP mRNA | CTD | PMID:31150632 | urethane | decreases expression | ISO | RGD:1606467 | 6480464 | Urethane results in decreased expression of NR2C2AP mRNA | CTD | PMID:28818685 | valproic acid | increases expression | ISO | RGD:1606467 | 6480464 | Valproic Acid results in increased expression of NR2C2AP mRNA | CTD | PMID:23179753 | valproic acid | increases methylation | ISO | RGD:1606467 | 6480464 | Valproic Acid results in increased methylation of NR2C2AP gene | CTD | PMID:29154799 | |